How Much Profit Should Novartis Earn By Curing A Childhood Leukemia?
Putting artificial caps on profitability for drugs that add real value to patients is not the answer.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NYSE:NVS Source Type: news
More News: Leukemia | Pharmaceuticals